Advertisement

Pharmacy

Purdue Pharma filed for bankruptcy protection Sept. 15 as part of a strategy to protect itself and its owners from thousands of lawsuits alleging it helped fuel the U.S. opioid epidemic. 

An FDA advisory panel endorsed Sept. 13 the first protective therapy for peanut allergies, according to STAT.

Advertisement

Embattled OxyContin maker Purdue Pharma filed for bankruptcy on Sept. 15, according to The New York Times. 

The Drug Enforcement Administration is proposing to set more stringent limits on the amount of opioids the U.S. is allowed to produce, according to Drug Topics.

Medical device and drug recalls, whether voluntary or forced by the FDA, ensure patient safety. Here are five reported by Becker's Hospital Review in the last two weeks:

Advertisement